These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1778876)

  • 21. Evaluation of restoration of sensitivities of resistant Staphylococcus aureus isolates by using cefuroxime and clavulanic acid in combination.
    Jalil A; Niazi ID; Khan SU
    J Ayub Med Coll Abbottabad; 2008; 20(2):28-30. PubMed ID: 19385452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models.
    Cohen MA; Wold SA; Meservey MA; Gage JW; Heifetz CL; Mailloux GB; Roland GE; Yoder SL
    Diagn Microbiol Infect Dis; 1994 Jan; 18(1):41-7. PubMed ID: 8026156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue.
    Nannini EC; Singh KV; Murray BE
    Clin Infect Dis; 2003 Nov; 37(9):1194-8. PubMed ID: 14557964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
    J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of cefcanel on staphylocci.
    Bergan T; da Fonseca J
    Chemotherapy; 1991; 37(1):43-9. PubMed ID: 2013241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of four beta-lactamases produced by Staphylococcus aureus.
    Zygmunt DJ; Stratton CW; Kernodle DS
    Antimicrob Agents Chemother; 1992 Feb; 36(2):440-5. PubMed ID: 1605608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. I. Effect of NaCl.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Apr; 48(4):553-62. PubMed ID: 7783318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-inoculum model of surgical wound infection.
    Kaiser AB; Kernodle DS; Parker RA
    J Infect Dis; 1992 Aug; 166(2):393-9. PubMed ID: 1634811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on phage type, beta-lactamase activity and sensitivity of multiple drug-resistant Staphylococcus aureus isolated from clinical specimens to cefmetazole].
    Toyonaga Y; Kurosu Y; Sugita M; Kumagai K; Hori M; Hoshina S; Kurosaka K; Nishiyama H; Shinohara N; Takahashi T; Deguchi K 210 P
    Jpn J Antibiot; 1982 Jul; 35(7):1673-85. PubMed ID: 6217356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial drug susceptibility of Staphylococcus aureus strains isolated from bovine milk.
    Franklin A; Horn af Rantzien M
    Nord Vet Med; 1983 Dec; 35(12):460-4. PubMed ID: 6609347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin.
    Bouchenaki N; Vaudaux PE; Huggler E; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1990 Jan; 34(1):21-4. PubMed ID: 2109574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro, Hollow-Fiber Model.
    Smith JR; Arya A; Yim J; Barber KE; Hallesy J; Singh NB; Rybak MJ
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3970-5. PubMed ID: 27090172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.
    Nannini EC; Stryjewski ME; Singh KV; Rude TH; Corey GR; Fowler VG; Murray BE
    Antimicrob Agents Chemother; 2010 May; 54(5):2206-8. PubMed ID: 20211890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical prophylaxis: how far have we really come?
    Kernodle DS
    Pharmacotherapy; 1988; 8(6 Pt 2):11S-13S. PubMed ID: 3075742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefamandole versus cefazolin in vascular surgical wound infection prophylaxis: cost-effectiveness and risk factors.
    Edwards WH; Kaiser AB; Tapper S; Edwards WH; Martin RS; Mulherin JL; Jenkins JM; Roach AC
    J Vasc Surg; 1993 Sep; 18(3):470-5; discussion 475-6. PubMed ID: 8377241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Surg Infect (Larchmt); 2016 Aug; 17(4):443-7. PubMed ID: 26990170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.